Blogs
Healthcare and Medtech Research Reports
Oct 05, 2026
Summary Migraine affects approximately one in seven people globally and remains underdiagnosed and undertreated. Migraine care has shifted from repurposed drugs such as antihypertensives, antidepressants, and anticonvulsants toward mechanism-specific therapies targeting the CGRP pathway. Unlike triptans, ...
Read More...
Sep 30, 2026
Migraine has always been treated as a pill problem. Take something, wait, and hope it works before the pain peaks. Digital migraine treatment devices are quietly upending that assumption, offering people a way to interrupt an attack or prevent one from building in the first place, using electrical, magnetic, or sen...
Read More...
Nov 29, 2021
Migraine is the most commonly encountered disabling disorder that can be featured as attacks of severe, unilateral, and a pulsating form of headache composed of symptoms such as photophobia, phonophobia, nausea, vomiting, and cutaneous allodynia. As per the Migraine Research Foundation 2021, Migraine is considered ...
Read More...
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer
Aug 05, 2026
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Newsletter/Whitepaper